1-3 of 3
M Schulze
Close
Sort by
Journal Articles

High CR-Rate after Intensive Chemotherapy but Disappointing Results after Palliative Treatment in Patients with Acute Myeloid Leukemia Above the Age of 60 Years: An Analysis of the AML97#38 Study of the East German Hematology and Oncology Study Group (OSHO).

Cornelia Becker, R. Krahl, H.K. Al Ali, W. Poenisch, M. Cross, S. Heyn, A. Gerhardt, A. Schulze, U. Mahlknecht, D. Haehling, M. Schulze, M. Freund, E. Kettner, G. Doelken, H.H. Wolf, E. Zschuppe, N. Peter, A. Franke, U. Wedding, L. Uharek, U. Kreibich, A. Florschuetz, B. Opitz, N. Zojer, W. Helbig, Dietger Niederwieser
Journal: Blood
Blood (2007) 110 (11): 1854.
https://doi.org/10.1182/blood.V110.11.1854.1854
Published: 2007
Journal Articles

Combination of Transplantation of Haploidentical Human Mesenchymal Stem Cells and Rituximab Therapy in a Patient with Extensive Therapy-Refractory Chronic Graft Versus Host Disease.

L. Mueller, M. Christopeit, J. Luetzkendorf, K. Reichelt, E. Schlesinger, M. Schulze, G. Behre
Journal: Blood
Blood (2006) 108 (11): 5290.
https://doi.org/10.1182/blood.V108.11.5290.5290
Published: 2006
Journal Articles

Binding of fluorescein-labeled anaphylatoxin C5a to human peripheral blood, spleen, and bone marrow leukocytes

T Werfel, M Oppermann, M Schulze, G Krieger, M Weber, O Gotze
Journal: Blood
Blood (1992) 79 (1): 152–160.
https://doi.org/10.1182/blood.V79.1.152.152
Published: 1992